Literature DB >> 27767033

Parkinson disease: LAG3 facilitates cell-to-cell spread of α-synuclein pathology.

Heather Wood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27767033     DOI： 10.1038/nrneurol.2016.164

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3.

Authors:  Xiaobo Mao; Michael Tianhao Ou; Senthilkumar S Karuppagounder; Tae-In Kam; Xiling Yin; Yulan Xiong; Preston Ge; George Essien Umanah; Saurav Brahmachari; Joo-Ho Shin; Ho Chul Kang; Jianmin Zhang; Jinchong Xu; Rong Chen; Hyejin Park; Shaida A Andrabi; Sung Ung Kang; Rafaella Araújo Gonçalves; Yu Liang; Shu Zhang; Chen Qi; Sharon Lam; James A Keiler; Joel Tyson; Donghoon Kim; Nikhil Panicker; Seung Pil Yun; Creg J Workman; Dario A A Vignali; Valina L Dawson; Han Seok Ko; Ted M Dawson
Journal:  Science       Date:  2016-09-30       Impact factor: 47.728
  1 in total
  4 in total

Review 1.  Vertebrate food products as a potential source of prion-like α-synuclein.

Authors:  Bryan Andrew Killinger; Viviane Labrie
Journal:  NPJ Parkinsons Dis       Date:  2017-11-24

Review 2.  Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson's Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading Pathology.

Authors:  Efthalia Angelopoulou; Yam Nath Paudel; Chiara Villa; Mohd Farooq Shaikh; Christina Piperi
Journal:  Biology (Basel)       Date:  2020-04-23

Review 3.  Diet in Parkinson's Disease: Critical Role for the Microbiome.

Authors:  Aeja Jackson; Christopher B Forsyth; Maliha Shaikh; Robin M Voigt; Phillip A Engen; Vivian Ramirez; Ali Keshavarzian
Journal:  Front Neurol       Date:  2019-12-10       Impact factor: 4.003

4.  LAG3 is not expressed in human and murine neurons and does not modulate α-synucleinopathies.

Authors:  Marc Emmenegger; Elena De Cecco; Marian Hruska-Plochan; Timo Eninger; Matthias M Schneider; Melanie Barth; Elena Tantardini; Pierre de Rossi; Mehtap Bacioglu; Rebekah G Langston; Alice Kaganovich; Nora Bengoa-Vergniory; Andrès Gonzalez-Guerra; Merve Avar; Daniel Heinzer; Regina Reimann; Lisa M Häsler; Therese W Herling; Naunehal S Matharu; Natalie Landeck; Kelvin Luk; Ronald Melki; Philipp J Kahle; Simone Hornemann; Tuomas P J Knowles; Mark R Cookson; Magdalini Polymenidou; Mathias Jucker; Adriano Aguzzi
Journal:  EMBO Mol Med       Date:  2021-07-26       Impact factor: 12.137
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.